Welcome to the first participants on the RADAR Study
The NICRF welcomes the first participants of the RADAR Study: Reducing Pathology in Alzheimer’s Disease Through Angiotensis Targeting. The RADAR Trial
Dr Bernadette McGuinness, Principal Investigator within the , School of Medicine, Dentistry and Biomedical Sciences, QUB, is undertaking a Phase II, randomised, double-blind, placebo-control trial to evaluate the effect of Losartan on brain tissue in patients diagnosed with Alzheimer’s Disease.
Read more about the Study here.
